trimetazidine has been researched along with Body Weight in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, C; Li, X; Liu, X; Lu, S; Wu, C; Zhang, Y; Zhou, H | 1 |
| Akgüllü, Ç; Boyacıoğlu, M; Eryilmaz, U; Kum, C; Meteoğlu, I; Onbaşılı, OA; Saruhan, T | 1 |
| Chopra, K; Satyanarayana, PS | 1 |
3 other study(ies) available for trimetazidine and Body Weight
| Article | Year |
|---|---|
Trimetazidine improves hepatic lipogenesis and steatosis in non‑alcoholic fatty liver disease via AMPK‑ChREBP pathway.
Topics: AMP-Activated Protein Kinases; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Body Weight; Diet, High-Fat; Disease Models, Animal; Forkhead Box Protein O1; Gene Expression Regulation; Hep G2 Cells; Humans; Lipogenesis; Male; Mice; Non-alcoholic Fatty Liver Disease; Palmitates; Signal Transduction; Trimetazidine | 2020 |
The first histopathological evidence of trimetazidine for the prevention of contrast-induced nephropathy.
Topics: Animals; Antioxidants; Body Weight; Catalase; Contrast Media; Creatinine; Glutathione; Kidney; Kidney Diseases; Male; Malondialdehyde; Organ Size; Rats, Wistar; Superoxide Dismutase; Trimetazidine | 2014 |
Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine.
Topics: Animals; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Body Weight; Creatinine; Cyclosporine; Disease Models, Animal; Drinking; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Wistar; Systole; Thiobarbituric Acid Reactive Substances; Time Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2002 |